Good to see @anzuptrials.bsky.social #ENZAMET trial getting a mention during the #ChristopherSweeney talk and panel discussion at the ACTA Clinical Trials and Registries Symposium ‘Harnessing the value of clinic-genomic data from multiple phase 3 prostate cancer trials’ @profiand.bsky.social

Great to see Yu Yang Soon presenting a poster at ACTA Clinical Trials and Registries Symposium featuring @anzuptrials.bsky.social #ENZAMET study – ‘Estimating Treatment Effects After a Positive Initial Interim Analysis: Challenges and Considerations’ #ChristopherSweeney @profiand.bsky.social